Page last updated: 2024-08-17

acrylamide and Escherichia coli Infections

acrylamide has been researched along with Escherichia coli Infections in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Higashi, N; Igai, K; Kita, E; Matsuoka, K; Miyagawa, A; Natori, Y; Nishikawa, K; Samejima, Y; Terunuma, D; Watanabe, M; Watanabe, T; Yanoshita, R1

Other Studies

1 other study(ies) available for acrylamide and Escherichia coli Infections

ArticleYear
Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections.
    The Journal of infectious diseases, 2004, Feb-01, Volume: 189, Issue:3

    Topics: Acrylamide; Animals; Brain Chemistry; Carbohydrate Sequence; Disease Models, Animal; Dose-Response Relationship, Drug; Escherichia coli Infections; Escherichia coli O157; Female; Hemolytic-Uremic Syndrome; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Polymers; Protein Binding; Receptors, Cell Surface; Shiga Toxin 1; Shiga Toxin 2; Shiga Toxins; Trihexosylceramides; Trisaccharides

2004